Botulism Antitoxin (Trivalent, Equine) from Japan
This equine-derived antiserum neutralizes botulinum neurotoxins A, B, and E, used therapeutically for botulism poisoning. Classified in HTS 3002.12.00 as antisera prepared for therapeutic uses, including animal blood sources. It is purified to reduce hypersensitivity risks.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Obtain CDC import permit for antitoxins due to select agent status
• Provide equine plasma sourcing and purification certificates
• Refrigerated transport mandatory; declare temperature monitoring logs